Patients with long term chronic pain who benefit from neuromodulation often have residual pain, rehabilitation, and mental health co-morbidities that remain after successful neuromodulation implementation. Such patients can realize additional improvement by treating and attending to these co-morbidities. This session will focus on the latest medical, mental health, and regenerative medicine approaches to help optimize neuromodulation outcomes.
Upon completion of this educational activity, participants should be able to:
- Discuss the neurobiological mechanisms implicated to mediate the effects of mental health disorders on chronic pain.
- Explain how advances in neurobiology have led emerging treatments for neuropathic pain.
- Describe the mechanisms, evidence, and applications of stem cell therapy that could be complimentary to neuromodulation.
- Identify strategies to mitigate first line neuropathic pain adjuvant failures and when and what 2nd line agents may be useful to improve patient outcomes.
Non-Opioid Analgesics as Adjuncts to Optimize Outcomes
James Watson, MD
Novel and Emerging Therapies for the Treatment of Neuropathic Pain
Charles E. Argoff, MD
Moderating/Mediating Effects of Mental Health Disorders on Short and Long Term Outcomes
W Michael Hooten, MD
Regenerative Medicine as Add-On Therapy to Optimize Neuromodulation Outcomes
Jianguo Cheng, MD PhD
Faculty subject to change.